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Background: The ghrelin axis is involved in the regulation of metabolism, energy balance, and the immune,
cardiovascular and reproductive systems. The manipulation of this axis has potential for improving economically
valuable traits in production animals, and polymorphisms in the ghrelin (GHRL) and ghrelin receptor (GHSR) genes
have been associated with growth and carcass traits. Here we investigate the structure and expression of the
ghrelin gene (GHRL) in sheep, Ovis aries.
Results: We identify two ghrelin mRNA isoforms, which we have designated Δex2 preproghrelin and Δex2,3
preproghrelin. Expression of Δex2,3 preproghrelin is likely to be restricted to ruminants, and would encode truncated
ghrelin and a novel C-terminal peptide. Both Δex2 preproghrelin and canonical preproghrelin mRNA isoforms were
expressed in a range of tissues. Expression of the Δex2,3 preproghrelin isoform, however, was restricted to white blood
cells (WBC; where the wild-type preproghrelin isoform is not co-expressed), and gastrointestinal tissues. Expression of
Δex2 preproghrelin and Δex2,3 preproghrelin mRNA was elevated in white blood cells in response to parasitic worm
(helminth) infection in genetically susceptible sheep, but not in resistant sheep.
Conclusions: The restricted expression of the novel preproghrelin variants and their distinct WBC expression pattern
during parasite infection may indicate a novel link between the ghrelin axis and metabolic and immune function in
ruminants.Background
The peptide hormone ghrelin has a wide range of physio-
logical functions, including a role in appetite stimulation,
and energy balance and regulation of the immune and re-
productive systems [1-4]. Ghrelin is most abundantly
expressed in the stomach of monogastrics and the aboma-
sum (glandular stomach) of ruminants, and it is also
expressed in a wide range of other tissues [3,5-7]. In order
to bind and activate its cognate receptor, the growth hor-
mone secretagogue receptor 1a (GHSR1a), ghrelin is post-
translationally octanoylated by the enzyme ghrelin-O-acyl
transferase (GOAT) [8,9].
The ghrelin axis (which includes ghrelin, GHSR, and
GOAT) is a potential target for improving production in
ruminant species through the manipulation of feeding,* Correspondence: l.chopin@qut.edu.au
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unless otherwise stated.growth, body composition and immune and reproduct-
ive functions [10-12]. Ghrelin or GHSR polymorphisms
have been associated with enhanced food intake, growth
and body conformation in cattle [13,14], and GHSR
polymorphisms have been associated with carcass traits
in sheep [10]. GHSR mRNA expression was elevated in
the pituitary gland of a line of sheep selected for in-
creased fat cover, compared to a lean sheep selection
line [15]. Ghrelin and GHSR1a are thought to regulate
reproduction in many species and are expressed in re-
productive tissues of sheep [16-18].
We previously reported differential ghrelin expression
in the gut (mRNA) and blood (peptide) of sheep selected
for gastrointestinal nematode resistance compared to
susceptible sheep [19], suggesting that ghrelin may play
a role in the immunity to parasite infection. Here, we
report a detailed characterization of the ghrelin gene
(GHRL) in the sheep, Ovis aries, and the discovery of
novel ghrelin variants with distinct mRNA expression in
white blood cells in response to helminth infection.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Ghrelin gene structure
Partial structure and sequence of the ghrelin gene (GHRL)
has been determined in a number of ruminants including
cattle [20], sheep [21], goat [22] and water buffalo [23],
however, no complete gene structure exists for the sheep
gene. To investigate ghrelin gene structure and expression
in the sheep, 5′ RLM-RACE and RT-PCR (using primers
spanning the canonical exons 1 to 4 of preproghrelin)
were performed using abomasum (glandular stomach)
and white blood cells (WBC). For consistency, we follow
the exon numbering nomenclature of the human and
murine GHRL genes [24,25]. Sequence analysis of 5′
RLM-RACE products revealed two alternative transcrip-
tional start sites (TSS) present in a short 5′ untranslated
exon, 13–20 bp in length, which was previously termed
exon 0 (Figure 1A and B). These TSS were found in both
the abomasum and WBC.
Using RT-PCR we demonstrated that the canonical
preproghrelin variant (305 bp) is expressed in the abo-
masum and white blood cells (Figure 1C). Sequencing
confirmed that this 305 bp RT-PCR product consisted of
4 exons and the corresponding full-length transcript would
encode a 116 amino acid preproghrelin protein, identical to
the sheep reference sequence [GenBank: NM_001009721].
The canonical coding exons of the ovine ghrelin gene
are exons 1 (135 nt), 2 (114 nt), 3 (109 nt) and 4 (~150 nt).
Although the predominant form of preproghrelin is 117
amino acids (AA) in length and mature ghrelin is 28 AA in
most mammals, the ruminant form of preproghrelin is 116Figure 1 Characterization of the sheep ghrelin gene. (A) Identification
M = NEB molecular weight marker 100; no TAP = negative TAP control. (B)
shown as a black box, exon 1 as a grey box, introns as horizontal lines. Transcri
exon. The translation initiation site of preproghrelin is shown as ATG. (C) Ethidi
(305 bp), exon 2-deleted preproghrelin (Δex2 preproghrelin, 191 bp) and exon
the abomasum (Lane 3) and white blood cells (Lane 4) of sheep. The exon stru
boxes, and the positions of RT-PCR primers are indicated by arrows above exon
template control. (D) Predicted translation and alignment of sheep preproghre
above corresponding coding sequences. Wild-type preproghrelin code for a 27
preproghrelin code for a truncated 13 AA ghrelin peptide. Obestatin peptide (s
wild-type preproghrelin and Δex2 preproghrelin, whereas Δex2,3 preproghrelinAA and ghrelin is a 27 AA peptide, resulting from alterna-
tive splicing which removes a codon for glutamine
[20,22,26-28].
Two additional RT-PCR products, 191 bp and 82 bp
in size, were also amplified (Figure 1C). Sequencing re-
vealed that the 191 bp mRNA isoform [GenBank:
JQ655468] lacks exon 2 and has been designated Δex2
preproghrelin. Translation of Δex2 preproghrelin would
produce a 78 amino acid peptide, consisting of the pre-
proghrelin signal peptide, followed by a 55 amino acid
peptide that includes a C-terminally truncated ghrelin
peptide (13 amino acids) and the obestatin sequence
(which is encoded by exon 3) (Figure 1D). Interestingly,
although exon 2 is absent from the Δex2 preproghrelin
mRNA sequence, the open reading frame is conserved
in mammals (Figure 2A). Obestatin, a peptide hormone
derived from the ghrelin preprohormone [29], has inde-
pendent functions from its sibling peptide, including
autocrine/paracrine roles in the pancreas and adipose
tissue [30].
The 82 bp amplicon [GenBank: JQ655469] lack exons
2 and 3 and has been designated Δex2,3 preproghrelin.
Like exon 2-deleted preproghrelin, it is predicted that
translation of this variant would produce an 81 amino
acid peptide that contains the preproghrelin signal pep-
tide, followed by the first 13 amino acids of the mature
ghrelin peptide (Figure 1D). A unique 45 amino acid C-
terminal peptide (lacking obestatin) is predicted to fol-
low, as removal of the non-symmetrical exon 3 creates a
frame shift. In contrast to Δex2 preproghrelin which isof the ovine GHRL transcription start sites. 5′ RLM-RACE of abomasum.
Partial transcript sequence showing exon 0 and exon 1. GHRL exon 0 is
ption start sites in exon 0 are capitalized. Size (bp) are shown above each
um bromide stained agarose gel showing the expression of ghrelin
2,3-deleted preproghrelin (Δex2,3 preproghrelin, 82 bp) amplified from
cture corresponding to each RT-PCR product is depicted by the adjacent
s. Lane 1 contains a 100 bp molecular weight marker and Lane 2 the no
lin variants. The signal peptide, ghrelin and obestatin are shown as boxes
amino acid (AA) ghrelin peptide, while Δex2 preproghrelin and Δex2,3
equence indicated by a dotted line) is encoded by the C-terminus of the
has a unique 45 amino acid carboxyl terminal sequence.
Figure 2 Alignment of Δex2,3 preproghrelin and Δex2,3 preproghrelin. Alignment of (A) Δex2,3 preproghrelin and (B) Δex2,3 preproghrelin
peptide sequences. The exonic structure containing the sequence coding for the peptide is shown below the sequence. Downstream exon 4
sequence data was not available for the water buffalo and Δex2,3 preproghrelin for this species is shown as 73 amino acids.
Table 1 Tissue distribution of ‘wild-type’ preproghrelin,
the Δex2 preproghrelin and Δex2,3 preproghrelin variants
(encoded by GHRL), and GOAT (encoded by MBOAT4) in






Aorta + - - -
Abomasum + + + +
Bladder - + - -
Colon + + - +
Heart muscle + - - +
Hypothalamus + + - -
Kidney + - - +
Large intestine + + - +
Liver + + - +
Lung + + - +
MLN + + - +
Pancreas + + - +
Salivary gland + - - +
Skeletal muscle - - - +
Small intestine + + + +
Spleen + - - +
Trachea + - - -
Tooth + + - +
Vein + + - -
White blood
cells
- + + -
MLN denotes Mesenteric Lymph Node. + = expressed. - = not detected.
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family harbor an intact Δex2,3 preproghrelin open read-
ing frame (Figure 2B). This include sheep, goat, cow,
the water buffalo (Bubalus bubalis), and the antelope
Arabian oryx (Oryx leucoryx). The 45 amino acid pep-
tide sequence of Δex2,3 preproghrelin does not present
any known sequence motifs that could indicate its pos-
sible function (data not shown).
Expression of preproghrelin variants and the ghrelin
acylation enzyme in ovine tissues
The tissue distribution of ghrelin in sheep has been re-
ported previously [21]. In the earlier study, RT-PCR
primers spanned exons 2 and 4 of the ghrelin gene, ex-
cluding the possible amplification of the Δex2 preprogh-
relin and Δex2,3 preproghrelin variants. We screened 20
different cell and tissue types for wild-type preproghrelin
transcript, the two novel preproghrelin variants and the
ghrelin acylation enzyme GOAT (encoded by MBOAT4)
using RT-PCR. We found that the expression of wild-
type preproghrelin and the novel splice variants was tis-
sue specific (Table 1). Full-length preproghrelin was
expressed in all tissues examined, with the exception of
the urinary bladder, skeletal muscle and WBC (Table 1).
Δex2 preproghrelin expression was also detected in
many tissues, including the gastrointestinal tract (abo-
masum, small intestine, colon), lymphoid tissue (lymph
nodes and Peyer’s patches), lung, WBC, and urinary
bladder (Table 1). Interestingly, the expression of Δex2,3
preproghrelin was restricted to WBC, abomasum, small
intestine and lymphoid tissue associated with the small
intestine. The enzyme GOAT, (encoded by the gene
MBOAT4) catalyses the octanoylation of ghrelin, allow-
ing it to signal through its cognate receptor, GHSR1a
[8,9]. GOAT is expressed in the abomasum (glandular
stomach) and pancreas in sheep, and expression has
been demonstrated in equivalent tissues in other species[8,9,31]. GOAT expression was not detected in a num-
ber of sheep tissues that expressed ghrelin variants, in-
cluding white blood cells, lung and venous tissue
(Table 1), suggesting that the ghrelin peptide or ghrelin
peptide variants expressed in these tissues are not acylated.
Figure 3 Expression of ghrelin variants in white blood cells of
sheep and overview of the proximal promoter region of the
ovine ghrelin gene. Expression of ghrelin variant transcripts, Δex2
preproghrelin (A) and Δex2,3 preproghrelin (B) in white blood cells
from genetically resistant (dark grey diamond symbol) or susceptible
(light grey square symbol) sheep, following infection with Haemonchus
contortus, demonstrated using real time RT-PCR. Results at each time
point indicate mean and standard error from a group of 8 sheep.
(C) Promoter region of the ovine ghrelin gene (GHRL). Predicted
transcription factor binding sites are boxed and the transcription
factor families that target this sequence are shown below the sequence.
The transcription factor sites identified are also conserved in the
promoter region of bovine ghrelin. The TATA box, a consensus
sequence upstream of the transcription start site that plays a role
in transcription initiation, and the first exon of the ghrelin gene
(exon 0) are also shown.
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ghrelin), is also functional, but acts through an unidentified
alternative ghrelin receptor in some cell and tissues [32].
The Δex2 preproghrelin and Δex2,3 preproghrelin
variants are responsive to parasite infection
We noted that white blood cells expressed Δex2 pre-
proghrelin and Δex2,3 preproghrelin, but not wild-type
preproghrelin transcripts (Figure 1C and Table 1). On
the basis of these findings, we hypothesized that preprogh-
relin variants may be differentially expressed in response to
parasitic worm (helminth) infection. Blood samples were
generated in an earlier experiment in which sheep from
the parasite resistant and susceptible lines of a selection
flock were challenged with the highly pathogenic nema-
tode, Haemonchus contortus [33]. Expression of Δex2 pre-
proghrelin and Δex2,3 preproghrelin was determined in
white blood cells (WBC) at a number of time points after
infection (Figure 3A and B). While the wild-type preprogh-
relin was not amplified in any WBC samples (data not
shown), expression of both novel preproghrelin variants in-
creased in WBC in susceptible sheep 4 days after infection.
From day 10, expression of the variants remained constant.
Having established that the novel Δex2 preproghrelin
and Δex2,3 preproghrelin variants display a distinct ex-
pression pattern in white blood cells following parasite
infection, we interrogated the proximal promoter region
of the sheep ghrelin gene. As outlined above, RLM-
RACE (Figure 1A and B) revealed that WBCs harbor a
transcriptional start site in a short untranslated exon 0.
The sequence region upstream of exon 0 of ghrelin was
analysed for possible promoter features and transcrip-
tion factor binding sites. A candidate promoter region,
which is conserved between sheep and cattle, was identi-
fied in the first 450 bp upstream of exon 0 (Figure 3C).
A TATA box likely to provide an RNA polymerase
binding site for GHRL transcription initiation was
present 25 bp upstream of exon 0. Putative binding
sites for members of the Ccaat/Enhancer Binding Pro-
tein (CEBP), cAMP-responsive element binding pro-
teins (CREB), Krüppel-like factor (KLF) and specificity
factor (SP1F) transcription factor families were also
identified in this region. Three putative KLF-binding
sites are present in the promoter region within 450 base
pairs of the GHRL transcriptional start site in sheep.
KLF4 is highly expressed in the stomach and other cells
and tissues, has a similar expression pattern to ghrelin
and regulates human ghrelin gene expression in the hu-
man AGS stomach cell line [34]. The zinc finger tran-
scription factor KLF4 interacts with CREB and plays a
wide range of roles, including the regulation of cell
growth and differentiation [34]. Interestingly, evidence is
emerging that KLF4 is involved in the pathophysiology of
inflammatory diseases, including parasite infection [35-38].
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expression in response to helminth infection.
Variations on a theme: alternative splicing of the ghrelin
gene
A number of peptide preprohormones and neuropeptides
are alternatively spliced to produce different isoforms, or
peptides with different functions. It is now appreciated
that the ghrelin gene locus is a polyhormone locus that,
via alternative splicing and post-translational processing,
produces a number of bioactive peptides [25,32]. The
peptide hormone, obestatin, is derived from the ghrelin
preprohormone [29] and has functions which are inde-
pendent of ghrelin [30]. Other novel peptides derived
from isoforms of the ghrelin preprohormone may also
be functional [24,39-42].
We here describe two novel splice variants derived
from the sheep ghrelin gene. Both Δex2 preproghrelin
and Δex2,3 preproghrelin contain the conserved ghrelin
GSSFL amino acid motif, which is the minimum sequence
required for binding and stimulation of the ghrelin recep-
tor GHSR1a in vitro [43] and for acylation of ghrelin by
GOAT [44]. Although the truncated ghrelin variants are
likely to have shorter half-lives than full-length ghrelin
[45], these isoforms could have both endocrine effects
(such as appetite stimulation), as well as autocrine/
paracrine actions in peripheral tissues.
A previous study conducted in our laboratory showed
differential levels of ghrelin in the gut (mRNA) and
blood (peptide) of sheep selected for gastrointestinal hel-
minth resistance compared to susceptible sheep [19],
suggesting that ghrelin is associated with immunity to
parasite infection. Given a lack of wild-type preproghre-
lin and differential expression pattern in white blood cell
noted between the resistant and susceptible sheep in the
current study, these new variants are likely to play a role
in immunity. In particular, the finding that the expres-
sion of the Δex2,3 preproghrelin variant is limited to
white blood cells and the gut, suggests that there is a
direct link between tissues of the digestive tract and
circulating immune cells. Δex2,3 preproghrelin would
be translated into a peptide that contains the minimal
active region of ghrelin, and a novel 45 amino acid
peptide.
Conclusions
Although further larger studies are required, we specu-
late that Δex2 preproghrelin and Δex2,3 preproghrelin
are translated into bioactive peptides that function dur-
ing the early stage of an effective response to gastro-
intestinal nematodes. In addition, the variants and their
derived peptides may be useful in predicting susceptibil-
ity and resistance to parasitic infection. The recognition
of novel preproghrelin variants should aid in interpretingstudies linking expression of the ghrelin gene to pheno-
typic differences in ruminant production animals.
Methods
Animals
RNA samples from white blood cells and abomasum
from Merino sheep challenged with Haemonchus contor-
tus infection were generated for a previously reported
study [33], as described below. This RNA was used for
cloning of ghrelin variants and for characterization of
ghrelin gene structure. All related procedures were ap-
proved by the F. D. McMaster Animal Ethics Committee,
CSIRO Livestock Industries (AEC Approval No. 05/58). A
range of tissues were collected from three euthanized Me-
rino sheep in accordance with the Australian Code of
Practice for the Care and Use of animals for scientific pur-
poses and Innovation Animal Ethics Committee (SA
2009/09/297) and used to determine the tissue expression
of the ghrelin variants. Tissues were collected on ice, rap-
idly frozen using liquid nitrogen and stored at −80°C.
RNA extraction and reverse transcription
For each tissue sample, 50 mg frozen tissue was wrapped
in aluminum foil and immediately transferred to liquid
nitrogen. For RNA extraction, the tissue was pulverized
on a cold block using a hammer, scraped into RLT buf-
fer (QIAGEN, Hilden, Germany) and immediately ho-
mogenized for 2 × 60 s with 0.5 mm glass beads using a
Mini-Beadbeater (Biospec Products, Bartlesville, OK).
Total RNA was isolated from the homogenized tissues
using an RNeasy Plus Mini kit (QIAGEN), with genomic
DNA eliminator spin columns, according to the manufac-
turer’s instructions. Total RNA (2.5 μg) was subjected to a
further DNase I digestion (amplification grade, Invitrogen,
Carlsbad, CA) to ensure complete removal of genomic
contamination. RNA 260:280 nm absorbance ratios were
1.9-2.0 and 260:230 nm ratios were between 2.0 and 2.2.
For qualitative and quantitative RT-PCRs, cDNA was gen-
erated from 2 μg total RNA by reverse transcription using
oligo(dT)20 primers and 200 units SuperScript III (Invitro-
gen) in a final volume of 20 μL using a PTC-200 thermal
cycler (MJ Research, Watertown, MA), according to the
manufacturer’s instructions. The resulting single-stranded
cDNA was treated with ribonuclease H (Invitrogen).
Identification of transcription start sites of the sheep
ghrelin gene
5′ rapid amplification of cDNA ends (RACE) was under-
taken using the FirstChoice RNA ligase mediated
(RLM)-RACE kit (Invitrogen) according to the manufac-
turer’s instructions. Briefly, 20 μg total RNA was treated
with 1.5 U shrimp alkaline phosphatase (Fermentas,
Glen Burnie, MD) in a 25 μl total reaction volume. Next,
10 μL phosphatase treated RNA was treated with 5 U
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technologies, Madison, WI) in a 50 μL reaction to uncap
intact RNA. The remaining 10 μL was employed in a
no-TAP control reaction, where TAP was substituted
with water. RNA was purified using an RNeasy Mini
cleanup kit (QIAGEN) and eluted in 12 μL RNase-free
water. Next, 0.3 μg/μl of 5′ RACE adapter (Ambion)
was ligated to the eluted RNAs in a total volume of
30 μl using 30 U T4 RNA ligase (New England Biolabs,
Ipswich, MA). Following a 16 h incubation at 17°C in a
PTC-200 thermal cycler (MJ Research), the adapter-
ligated RNA was purified (as before) and eluted in 10 μl.
Adapter-ligated total RNA (2 μg) from the abomasum and
white blood cells was reverse transcribed with 200 units
SuperScript III (Invitrogen) using oligo(dT)20 primers in a
final volume of 20 μl, according to the manufacturer’s in-
structions. All enzymatic (SAP, TAP, reverse transcription)
reactions contained 40U RNasin Plus ribonuclease in-
hibitor (Promega, Fitchburg, WI). Following reverse
transcription, the RACE-ready cDNA was treated with
2U of RNase H (Invitrogen) according to the manufac-
turer’s instructions.
The first round of RT-PCR was performed with an
adapter-specific forward primer and a GHRL-specific re-
verse primer (5OF/R, Table 2). The RT-PCR product
(1 μL) was diluted 1/10 in water and then used in a sec-
ondary, nested RT-PCR (5IF/R, Table 2). RT-PCRs were
performed in a total reaction volume of 50 μL using 1 U
Platinum Taq Polymerase (Invitrogen), according to the
manufacturer’s instructions. RT-PCR products were puri-
fied using a PureLink PCR Purification Kit (Invitrogen),Table 2 Primer sequences used for qualitative and quantitati
product size
Primer name Assay Sequence (5′-3′) Exon position
GHRL-1 F RT-PCR TTTCTGAGCCCTGAACATCAG 1
GHRL-4R GAGAACAGACAGGTGGTTGG 4
GHRL-5OF RACE ATGAATGAACACTGCGTTTGCT N/A
GHRL-5OR CAGTTTCTGATGTTCAGGGCTC 1
GHRL-5IF RACE GAACACTGCGTTTGCTGGCT N/A
GHRL-5IR GGCCAAGTCCATCCAGAGCA 1
GHRL-2F qRT-PCR CTAAGAAGCCGTCAGGCAGACT 2
GHRL-2R GGGACTGAGCCCCTGACA 3
GHRL1_3F qRT-PCR CAGAAACTGCAGTTCAATGC 1 / 3
GHRL-4R CACGTGGTCTCGGAAGTGT 4
GHRL1_4F qRT-PCR CTGCAGAAACCCTGGCTGA 1 / 4
GHRL-4R CACGTGGTCTCGGAAGTGT 4
GOAT-mF qRT-PCR GGTTTCAAGCTCGAGTTGAAGG N/A
GOAT-mR AGTAGGTGAGTTTGAAGAGCCC
GAPDH-F qRT-PCR CCTGGAGAAACCTGCCAAGT N/A
GAPDH-R GCCAAATTCATTGTCGTACCAcloned into pTargeT (Promega), and transformed into
TOP10 chemically-competent cells (Invitrogen). Sequen-
cing reactions were performed using a BigDye Terminator
Cycle Sequencing Kit v3 (Applied Biosystems, Foster City,
CA, USA) on an ABI PRISM 3100-Avant Genetic Analyzer
(Applied Biosystems), after pre-sequencing clean up of ex-
cess dye terminator with a CleanSEQ Sequencing Reaction
Cleanup Kit (Agencourt Bioscience Corporation, Beverly,
MA, USA).
In silico promoter analysis
The promoter region of the ovine ghrelin gene was an-
notated using the Genomatix (Munich, Germany) suite
of programs. As the sheep genome sequence had yet to
be released, the region upstream of exon 0 of the bovine
GHRL gene was used for initial development of a pro-
moter model. The MatInspector program was then used
to identify possible transcription factor binding sites
within each model. Stringent criteria were used in this
stage of analysis with a minimum core similarity of 1
and matrix similarity of 0.9 selected. The bovine region
was then aligned to the region upstream of the ovine
GHRL gene transcriptional start site. Regions conserved
between the bovine and ovine sequences were conserved
candidate promoter elements.
Non-quantitative expression of preproghrelin variants
and the ghrelin acylation enzyme GOAT
RT-PCR primers (Table 2) were designed to examine the
splicing pattern of preproghrelin mRNAs (encoded by
GHRL), as well as the expression of the ghrelin acylationve (q) real time RT-PCR, and RACE and the expected
Target gene Amplicon sizes (bp)




GHRL (Δex2 preproghrelin) 224
GHRL (Δex2,3 preproghrelin) 109
MBOAT4 (GOAT) 212
GAPDH 209
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variants were amplified using primers in the terminal
coding exons (exons 1 and 4) of the canonical (wild-
type) preproghrelin coding sequence. RT-PCRs were
performed using 200 ng cDNA, and 1 U Platinum Taq
HIFI Polymerase (Invitrogen) in a final volume of 50 μL
using a PTC-200 thermal cycler (MJ Research), accord-
ing to the manufacturer’s instructions. RT-PCR prod-
ucts were separated by electrophoresis on a 2% agarose
gel in Tris-acetate-EDTA (TAE) buffer, stained with
ethidium bromide and visualised using ultraviolet light.
RT-PCR products were purified using a PureLink PCR
Purification Kit (Invitrogen), or a MinElute PCR Purifica-
tion kit (QIAGEN), cloned into pTargeT (Promega), and
transformed into TOP10 chemically-competent cells (Invi-
trogen). Sequencing reactions were as outlined above.
Bioinformatic alignment of ghrelin peptide variants
Preproghrelin exon sequences were obtained by BLAST
alignments [46] against nucleotide sequences available in
the NCBI GenBank database. The recently released draft
genome sequence (oryxL1) of the Arabian oryx (Oryx
leucoryx) was obtained [47] and interrogated using a
local instance of BLASTn available in v2.2.26+ of the
BLAST + suite [48]. We acknowledge the efforts of the
Weill Cornell Medical College in Qatar (WCMCQ) Gen-
omics Core, the Biotechnology Centre of the Ministry of
Environment (Qatar) and Wabra Wildlife Preservation
(Qatar) in generating the oryx genome sequence. The
obtained nucleotide sequences were converted to protein
sequences using the ExPASy Translate tool [49] and
aligned using MUSCLE [50].
Quantitative real time reverse transcription (RT-)PCR
Real time RT-PCR assays were designed to quantify expres-
sion of canonical ovine preproghrelin transcript (GHRE-
2 F/2R), Δex2 preproghrelin (GHRL1_3F/4R) and Δex2,3
preproghrelin (GHRL1_4F/4R) in white blood cells
(WBC) following infection with the parasitic helminth
Haemonchus contortus (Table 2). Real time RT-PCRs
for the housekeeping gene, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), were performed using the
GAPDH-F/R primer pair, as previously described [51].
Briefly, white blood cells (WBC) were collected from
Merino sheep exposed to a gastrointestinal helminth
challenge with H. contortus, as outlined in a previous
study [33]. Groups of 8 sheep bred for parasite resist-
ance and 8 sheep bred for parasite susceptibility were in-
dividually dosed with a bolus of 5,000H. contortus L3
infectious larvae (Kirby strain). Blood was collected im-
mediately prior to infection (day 0) and on days 4, 14, 28
and 42 post-infection. White blood cells were isolated
from each blood sample, RNA extracted and cDNA syn-
thesized, as described above.Real time RT-PCR was performed using the ABI Prism
7900HT sequence detection system (Applied Biosys-
tems). Each reaction contained 1 × SYBR Green Master
Mix (Applied Biosystems), 900 nM each primer and a
constant amount of cDNA (corresponding to 10 ng of
reverse transcribed RNA for each sample). Three tech-
nical replicates were included for each candidate gene.
For each of the biological samples, gene expression was
quantified by normalizing each target gene against the
expression of the reference gene, GAPDH, using the Q-
GENE statistical analysis package [52]. Q-GENE calcu-
lates a Mean Normalised Expression (MNE) ± Standard
Error (SE), correcting for amplification efficiencies.
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